In vivo and in vitro degradation of glucagon-like peptide-2 in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 8, 2000, Pages 2884-2888

  Hartmann, Bolette ^a   Harr, Mette B ^a   Jeppesen, Palle B ^b   Wojdemann, Morten ^b   Deacon, Carolyn F ^a   Mortensen, Per B ^b   Holst, Jens J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 2;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE EXPRESSION; GROWTH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTESTINE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; RADIOIMMUNOASSAY;

ADULT; ANIMALS; FEMALE; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; KINETICS; MALE; MICE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDES; POSTPRANDIAL PERIOD; RATS; RECOMBINANT PROTEINS;

EID: 0034457973     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.8.2884     Document Type: Article

References (17)

1. Enteroglucagon
2. Induction of intestinal epithelial proliferation by glucagon-like peptide 2
3. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
4. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2
5. Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans
6. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum
7. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs
8. Assays for peptide products of somatostatin gene expression
9. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo
10. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig
11. Dipeptidyl-peptidase. IV. CD26: Role in the inactivation of regulatory peptides
12. Degradation of Glucagons
13. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine
14. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects
15. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients
16. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes
17. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity